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S122 DialysisCI, 1.65e12.81) were associated with a significantly higher risk of cardiovas-
cular mortality.
Conclusion: In CAPD patients, overweight was associated with uncontrolled
BP and uncontrolled SBP, and uncontrolled SBP was associated with an
increased risk of cardiovascular mortality. Patients with concurrent under-
weight and uncontrolled BP, as well as underweight and uncontrolled SBP
had significantly higher risk of cardiovascular mortality.http://dx.doi.org/10.1016/j.hkjn.2015.09.186
0141
Impact of Type D Personality on Quality of Life in CAPD Patients
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University, Guangzhou, China
Objective: Type D personality is a stable and powerful predictor of
impaired quality of life and poor health outcomes in various patient
groups and healthy individuals. We attempted to assess the relation-
ships among Type D personality, illness perception, social support and
depression, and investigate the impact of Type D personality on quality
of life (QOL) in continuous ambulatory peritoneal dialysis (CAPD)
patients.
Methods: The demographic information, clinical data and laboratory find-
ings in CAPD patients in our PD center from September, 2012 to
September, 2013 were collected. Type D personality was assessed by the
Chinese 14-item Type D Personality Scale (DS14). Patients’ illness percep-
tion, social support, depression, and QOL were assessed by using the Brief
Illness Perception Questionnaire (Brief IPQ), social support rating scale
(SSRS), Beck Depression Inventory (BDI), and Short Form 36 (SF-36),
respectively.
Results: Of the 385 CAPD patients investigated, 137 (35.6%) patients had
a Type D Personality (Type Ds). Type Ds believed their illness had much
more serious consequences (7.67 2.64 vs. 6.27 3.45, P < 0.001), and
experience much more symptoms that they attributed to their illness
(7.11 3.58 vs. 5.93 2.59, P Z 0.023). Significant differences were
found between Type Ds and non-Type Ds in QOL (395.2 130.34 vs.
489.6 148.38, P < 0.001), social support (21.7 5.42 vs. 24.93 5.83,
P < 0.001), and depression (22.9% vs. 20.4%, P < 0.001). The correlation
analysis demonstrated that Type D was positively associated with depres-
sion (r Z 0.384, P < 0.01), while negatively associated with SF-36 score
(r Z .301, P < 0.01), and social support (r Z 0.254, P < 0.01). Using
multiple linear regression analysis, we found that Type D personality
(b Z 82.554, P < 0.001) was independently associated with SF-36
score.
Conclusion: Type D personality was a predictor of poor QOL in PD patients.
Our results suggest that intervention for Type Ds may benefit CAPD patients
in terms of QOL improvement.http://dx.doi.org/10.1016/j.hkjn.2015.09.1870143
miR-200a Negatively Regulates TGF-b1-induced Peritoneal Mesothelial
Cell Epithelial-Mesenchymal Transition by Targeting ZEB1 and ZEB2
Expression
Xin Wei, Guojun Hao, Qinkai Chen
The First Affilated Hospital of Nan Chang University, Nan Chang, China
Background: Peritoneal fibrosis (PF) is an almost invariable consequence
of peritoneal dialysis (PD), which is an established alternative for the
replacement therapy of end-stage renal disease. In our previous study,
we found that the expression level of miR-200a were down-regulated in
fibrotic peritoneum and the epithelial-mesenchymal transition (EMT) pro-
cess of peritoneal mesothelial cell. However, the role of miR-200a in
EMT of peritoneal mesothelial cell and peritoneal fibrosis is largely
unknown.
Methods: Human peritoneal mesothelial cell line (HMrSV5) was cultured in
the presence or absence of TGF-b1. The protein expression levels of EMTindex and E-box-binding homeobox (ZEB) 1/2 were determined by western
blot. The level of miR-200a was determined by real-time PCR. miR-200a
mimic or inhibitor and it negative control RNA, were transfected into HMrSV5
cells using Liptofectamine 2000.
Results: We found that miR-200a mimic can attenuated TGF-b1 induced
peritoneal mesothelial cell EMT and synthesis of extracellular matrix. It
was also demonstrated that the miR-200a was responsible for protecting
peritoneal mesothelial cells from mesenchymal transition by targeting sup-
pression of ZEB1/2.
Conclusion: The results suggested that miR-200a may not only be a useful
biomarker of EMT in ovarian cancer, but also of potential therapeutic value
in peritoneal fibrosis.Fig. 1 AeB: EMT index expression after transfection of miR-200a mimic or in-
hibitor. CeD: ZEB1/2 expression after transfection of miR-200a mimic.
*P < 0.5, #P < 0.01.http://dx.doi.org/10.1016/j.hkjn.2015.09.1880144
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Background: Peritoneal fibrosis (PF) is an almost invariable consequence of
peritoneal dialysis (PD), which is an established alternative for the replace-
ment therapy of end-stage renal disease. We know that miR-200a belong to
miR-200 family, which is closely related to a variety of fibrotic diseases.
However, the role of miR-200a in peritoneal fibrosis is largely unknown.
Methods: The peritoneal fibrosis mouse model associated with PD was estab-
lished by intraperitoneal injection of lipopolysaccharide + 4.25% peritoneal
dialysate. The expression of miRNA was detected by microarray. The expres-
sion of miRNA profiles between fibrotic and normal peritoneal tissues was
compared (n Z 3 in each group). The differentially expressed miRNA
(miR-200a) was validated by realetime PCR in lager sample size cohorts
(n Z 15). The expressions of miR-200a were also detected in the epithe-
lialemesenchymal transition (EMT) process of peritoneal mesothelium cells.
Results: In mice model of PD, peritoneal tissue was markedly thickened and
with a massive extracellular matrix accumulation. By miRNA microarray
analysis, miRe200a was significantly down regulated (3.31 folds change,
Dialysis S123P < 0.05) infibrotic peritoneal tissues. The down-regulated expression level
of miRe200a was also validated by real-time PCR in larger cohorts
(P < 0.05). Then, the expression level of miRe200a was detected in the
EMT process of human peritoneal mesothelium cells. During the process of
TGFeb1 induced EMT, miRe200a was significantly downeregulated
compared with the control (P < 0.05).
Conclusion: Down-regulated expression of miR-200a was observed both dur-
ing peritoneal fibrosis and TGF-b1 induced EMT in vivo and in vitro, suggest-
ing that miR-200a may be involved in the peritoneum fibrosis by regulating
the target genes of EMT.
Fig. 1. A, B: peritoneal fibrosis in a mouse model of PD. C, D: peritoneal
fibrosis index expression. E, F: EMT index expression during the EMT process
of human peritoneal mesothelium cells. G: miR-200a expression level down-
regulated during the EMT process. NPT: normal peritoneal tissue, FPT:
fibrotic peritoneal tissue,* P < 0 05, )) P < 0.01.http://dx.doi.org/10.1016/j.hkjn.2015.09.189
0145
Association Between Compliance with Visiting Nephrologist and Clinical
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Objective: To investigate the association between compliancewith visiting the
nephrologists and clinical outcomes of remote PD patients in Southern China.
Methods: In this retrospective cohort study, incident remote (travel distance
50 km) PD patients in our PD center from January 2006 to December 2012were enrolled and followed up until December 2014. According to the time
intervals of visiting the attending nephrologists, the patients were divided
into regular visiting group (1e6 months) and irregular visiting group (>6
months). The clinical outcomes were compared between the two groups.
Results: A total of 966 incident remote PD patients whose mean age was
45.9 14.4 years were enrolled. 38.0% of these patients were female, and
19.3% of them were diabetic. The median duration on PD was 36.0
(20.8e51.5)months. Comparedwith irregular visiting group (nZ 154), patients
with regular visiting (nZ 812) had higher levels of hemoglobin, serum albumin,
serum calcium, and lower systolic blood pressure, serum phosphorus, serum
creatinine (all p< 0.05). Theperitonitis rate of patients in regular visiting group
was significantly lower than that in irregular visiting group (0.15 vs. 0.20 epi-
sodes per patient-year, p< 0.001). The technique survival rateswerenot signif-
icantly different between the two groups. At the end of 1, 3, and 5 years,
patient survival rates were 97.2%, 88.1% and 76.0% in regular visiting group,
and 89.9%, 71.1% and 52.4% in irregular visiting group (p < 0.001). Advanced
age [hazard ratio (HR), 1.05 (95% CI, 1.03e1.06); p < 0.001], diabetes mellitus
[HR, 2.15 (95% CI, 1.44e3.21); p< 0.001], lower hemoglobin [HR, 0.99 (95% CI,
0.98e0.99); pZ 0.01] and poor compliance for visiting the attending nephrol-
ogists regularly [HR, 2.49 (95% CI, 1.69e3.68); p < 0.001] were risk factors for
all-cause mortality after adjustment for travel distance, gender, high-sensi-
tivity C-reactive protein, urine output, serum albumin and uric acid.
Conclusion: Visiting the attending nephrologists regularly was associated
with better outcomes of the remote PD patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.1900148
Bioimpedance-guided Fluid Management Can Improve Clinical
Outcomes in Peritoneal Dialysis Patients: A Prospective Randomized
Control Trial
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Xue Qing Yu
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Objective: To investigate the influence of fluid management guided by bio-
impedance analysis (BIA) on clinical outcomes in peritoneal dialysis (PD)
patients.
Methods: This was a prospective randomized controlled trial registered on
the clinical trials website (No: NCT02000128). The prevalent PD patients
with volume overload [extracellular water (ECW) / total body water (TBW)
 0.40] were recruited from 1st July 2013 to 30th March 2014, and were ran-
domized to BIA group (fluid management guided by BIA) and control group
(guided by doctors’ experience) to reduce their fluid overload for 1 year.
Results: A total of 240 eligible participants (mean age of 49.6 15.4, 50.8%
male) with a median vintage of 32 (17, 50) months were enrolled. At the end
of the study, 11 (4.58%) patients died, 21 (8.75%)were permanently transferred
to HD and 11 (4.58%) to kidney transplant. The 1-year mortality was not statis-
tically different between the two groups (BIA vs. control: 2.5 vs. 6.7 events per
100 patient$year, p Z 0.12), while the technique survival had a trend to be
higher in the BIA group (90.8% vs. 82.5%, p Z 0.06). Less hospitalization was
observed in the BIA group (1/51 patient$months vs 1/27 patient$months,
p Z 0.01), among which the incidence of non-catheter associated infections
(17 episodes vs. 4 episodes, pZ 0.007) and emergency cases due to hyperten-
sion (11.1% vs. 5%, pZ 0.07) were significantly lower in the BIA group. In addi-
tion, the decline rate of ECW/TBW was much faster in the BIA group than the
control (p Z 0.02). The left ventricular mass index (200.12 47.43 vs
253.88 71.59 g/m2, p＜ 0.001), the nutrition status and inflammation were
significantly improved in the BIA group compared with the control.
Conclusion: Volume management guided by BIA is an efficient way to alle-
viate fluid overload and improve cardiac dilation and remodeling, therefore
decreasing the hospitalization rate and improving technique survival.http://dx.doi.org/10.1016/j.hkjn.2015.09.191
